RecruitingNCT05931419

High-Risk prostatE Cancer radiatiOn Versus surgERy

High-Risk prostatE Cancer radiatiOn Versus surgERy (RECOVER)


Sponsor

Comprehensive Cancer Centre The Netherlands

Enrollment

837 participants

Start Date

Feb 16, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective cohort study comparing robot-assisted radical prostatectomy and external beam radiotherapy combined with androgen deprivation therapy for high-risk non-metastatic prostate cancer in terms of health-related quality of life, functional outcomes, cost-effectiveness, progression-free survival and distant metastasis-free survival.


Eligibility

Sex: MALEMin Age: 50 YearsMax Age: 75 Years

Inclusion Criteria7

  • Histologically confirmed de novo non-metastatic high-risk prostate cancer.
  • cT3a-bN0M0, according to the 8th edition of the Tumour, Node, Metastasis (TNM) classification, with the exception that clinical T-stage will be based on digital rectal examination and magnetic resonance imaging (the highest stage will be used) and/or
  • International Society of Urological Pathology (ISUP) grade ≥4 and/or
  • Prostate-Specific Antigen (PSA) value at diagnosis greater than 20 ng/mL
  • Fit for treatment with either RARP or EBRT and ADT (WHO performance status 0-1)
  • Living in the Netherlands
  • Able to read and understand the Dutch language

Exclusion Criteria3

  • Histological types other than adenocarcinoma
  • Diagnosis and/or treatment in a hospital abroad
  • Treatment with Androgen Receptor Targeted Agents (ARTA) as part of the initial treatment plan

Locations(29)

Noordwest Ziekenhuisgroep

Alkmaar, Netherlands

Ziekenhuis Amstelland

Amstelveen, Netherlands

Amsterdam UMC

Amsterdam, Netherlands

Antoni van Leeuwenhoek Ziekenhuis

Amsterdam, Netherlands

BovenIJ ziekenhuis

Amsterdam, Netherlands

OLVG

Amsterdam, Netherlands

Wilhelmina Ziekenhuis

Assen, Netherlands

Rode Kruis Ziekenhuis

Beverwijk, Netherlands

Albert Schweitzer Ziekenhuis

Dordrecht, Netherlands

Catharina Ziekenhuis

Eindhoven, Netherlands

Admiraal de Ruyter Ziekenhuis

Goes, Netherlands

Martini ziekenhuis

Groningen, Netherlands

Universitair Medisch Centrum Groningen

Groningen, Netherlands

Saxenburgh Medisch Centrum

Hardenberg, Netherlands

St Jansdal

Harderwijk, Netherlands

Spaarne Gasthuis

Hoofddorp, Netherlands

Treant

Hoogeveen, Netherlands

Dijklander Ziekenhuis

Hoorn, Netherlands

Leids Universitair Medisch Centrum

Leiden, Netherlands

Canisius Wilhelmina Ziekenhuis

Nijmegen, Netherlands

Radboudumc

Nijmegen, Netherlands

Erasmus Medisch Centrum Rotterdam

Rotterdam, Netherlands

Franciscus Gasthuis & Vlietland

Rotterdam, Netherlands

Maasstad Ziekenhuis

Rotterdam, Netherlands

Ommelander Ziekenhuis

Scheemda, Netherlands

Haaglanden Medisch Centrum

The Hague, Netherlands

Verbeeten Instituut

Tilburg, Netherlands

Maxima Medisch Centrum

Veldhoven, Netherlands

Zaans Medisch Centrum

Zaandam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05931419


Related Trials